Last $31.10 USD
Change Today 0.00 / 0.00%
Volume 0.0
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 8:04 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mikael Dolsten Ph.D.

President of Worldwide Research and Development, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 1 different organizations across 3 different industries.

See Board Relationships
55$6,453,404
As of Fiscal Year 2013

Background*

Prof. Mikael Dolste, Ph.D. has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010. Prof. Dolsten serves as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsibility for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. Prof. Dolsten has spent approximately seventeen years ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Former Director

Education*

Unknown/Other Education
Weizmann Institute Of Science
PhD
Lund University
MD
Lund University
MD
Skåne University Hospital

Other Affiliations*

Annual Compensation*

Salary$1,148,750
Total Annual Compensation$1,148,750

Stock Options*

Restricted Stock Awards$1,835,542
All Other Compensation$164,512

Total Compensation*

Total Annual Cash Compensation$2,653,262
Total Short Term Compensation$1,148,750
Other Long Term Compensation$2,000,054
Total Calculated Compensation$6,453,404
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $31.10 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.